LANSING, MI--(Marketwire - June 14, 2011) - Kraig Biocraft Laboratories, Inc. (PINKSHEETS: KBLB) announced that it posted a copy of its recent shareholder conference call with Kim Thompson, the Company’s CEO and founder, on its corporate website. A link to the conference call can be found on the KraigLabs.com home page as well as on the News page.
Thompson made several notable announcements, ranging from laboratory developments, timelines and new technologies, to commercialization news.
Kraig is advancing towards commercialization very rapidly and Thompson stated that he is in early rounds of negotiation with manufacturers and distributers regarding recombinant spider silk. He estimated that the Company could begin to sell non-woven products this year and woven product sales next year.
The Company disclosed that the new commercial “Monster Hybrid” is a combination of the Company’s “Monster Silk” caterpillar and a commercial caterpillar strain. This is the platform that the Company is ramping-up for commercialization.
Thompson confirmed receipt of its first delivery of Zinc Fingers on June 10, consisting of two separate configurations, from Sigma-Aldrich. Thompson anticipates that the use of the Zinc Fingers will lead to corresponding laboratory related developments this fall.
Following the conference call, Kim Thompson stated, “The Zinc Finger technology will greatly accelerate our product research and development. In fact, within the next few days we will begin the process of actively creating new transgenics with this technology.”
Interested parties are invited to listen in at http://www.kraiglabs.com/Thompson_2011-06-10_0350PM.mp3.
About Kraig Biocraft Laboratories
Kraig Biocraft Laboratories is a fully reporting biotechnology company that recently achieved a series of scientific breakthroughs, with implications for the global textile industry. For further information, please visit www.KraigLabs.com.
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “develops,” “researching,” “research,” “potential,” “could” or other words or phrases of similar import. Similarly, statements in this release that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals should all be considered forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that its ability to further its research, and create commercially-viable products may be affected by the competitive environment, the Company’s financial condition and its ability to raise sufficient capital to meet the financial obligations of its business plan and to fund its continuing operations.
Contact:
Ben Hansel
(720) 288-8495
